Diagnostic approach to drug allergy.

The approach to drug hypersensitivity always comprises a clinical and a diagnostic workup. About 15% of drug side effects are due to hypersensitivity reactions. All types of immunological reactions can be induced by drugs, but type I and type IV reactions are seen most often. The initial judgment of the skin symptoms is therefore one of the key factors besides a stringent history of drug intake for a further diagnostic workup. The goal of a diagnostic workup is not only to identify the culprit drug, but also to defer the patient from similar drugs in order to prevent a second episode. In the case of missing alternatives and unidentified drug sensitivity, reexposure to the previous drug must be discussed; however, in severe cutaneous reactions this should generally be avoided.

[1]  G. Porebski,et al.  In vitro diagnosis of T cell‐mediated drug allergy , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  L. Venemalm,et al.  Evaluation of a New Routine Diagnostic Test for Immunoglobulin E Sensitization to Neuromuscular Blocking Agents , 2011, Anesthesiology.

[3]  J. Roujeau,et al.  A three-year-analysis of fixed drug eruptions in hospital settings in France. , 2010, European journal of dermatology : EJD.

[4]  W. Pichler,et al.  The complex clinical picture of side effects to biologicals. , 2010, The Medical clinics of North America.

[5]  M. Blanca,et al.  Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin , 2010, Allergy.

[6]  A. Bircher,et al.  The role of iodine in hypersensitivity reactions to radio contrast media , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  A. Zawodniak,et al.  In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug‐induced skin diseases , 2010, Allergy.

[8]  A. Abe,et al.  Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer. , 2010, The journal of medical investigation : JMI.

[9]  K. Syrigos,et al.  Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful? , 2010, Anti-cancer drugs.

[10]  M. Castells,et al.  Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity , 2010, Expert opinion on drug safety.

[11]  A. Buonomo,et al.  Cross‐reactivity and tolerability of imipenem in patients with delayed‐type, cell‐mediated hypersensitivity to β‐lactams , 2009, Allergy.

[12]  P. Harter,et al.  Carboplatin Hypersensitivity: Does Introduction of Skin Test and Desensitization Reliably Predict and Avoid the Problem? A Prospective Single-Center Study , 2009, International Journal of Gynecologic Cancer.

[13]  S. Halevy.  Acute generalized exanthematous pustulosis , 2009, Current opinion in allergy and clinical immunology.

[14]  E. Oren,et al.  Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. , 2009, The Journal of allergy and clinical immunology.

[15]  P. Baiardi,et al.  Correlation between atopy and hypersensitivity reactions during therapy with three different TNF-alpha blocking agents in rheumatoid arthritis. , 2009, Clinical and experimental rheumatology.

[16]  Jason C. Gallagher,et al.  Allergic Cross-Sensitivity Between Penicillin, Carbapenem, and Monobactam Antibiotics: What are the Chances? , 2009, The Annals of pharmacotherapy.

[17]  A Romano,et al.  Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study , 2009, Allergy.

[18]  P. Bousquet,et al.  Diagnosing Hypersensitivity Reactions to Cephalosporins in Children , 2008, Pediatrics.

[19]  M. Castells,et al.  Hypersensitivity to antineoplastic agents. , 2008, Current pharmaceutical design.

[20]  R. Girot,et al.  Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  J. Nicolas,et al.  [Tolerability of oral administration of carboxymethylcellulose in two patients presenting anaphylactic reaction after carboxymethylcellulose injection]. , 2008, Annales de dermatologie et de venereologie.

[22]  B. Cunha,et al.  Safety of Meropenem in Patients Reporting Penicillin Allergy: Lack of Allergic Cross Reactions , 2008, Journal of chemotherapy.

[23]  A. Buonomo,et al.  Tolerability of Aztreonam in Patients with IgE-Mediated Hypersensitivity to Beta-Lactams , 2008, International journal of immunopathology and pharmacology.

[24]  B. Hoz,et al.  Immediate allergic reactions by polyethylene glycol 4000: two cases , 2008 .

[25]  E. Özkaya,et al.  Fixed drug eruption:state of the art , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[26]  A. Romano,et al.  Tolerability of meropenem in children with IgE‐mediated hypersensitivity to penicillins , 2008, Allergy.

[27]  T. Shiohara,et al.  Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption , 2007, Allergy.

[28]  W. Pichler,et al.  CD69 upregulation on T cells as an in vitro marker for delayed‐type drug hypersensitivity , 2007, Allergy.

[29]  A. Barbaud,et al.  Érythème polymorphe bulleux et trihexiphénidyle (ou pourquoi un bon interrogatoire n'est pas toujours policier) , 2007 .

[30]  L. Venemalm,et al.  Immunoglobulin E Antibodies to Rocuronium: A New Diagnostic Tool , 2007, Anesthesiology.

[31]  E. Bröcker,et al.  Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. , 2007, The Journal of antimicrobial chemotherapy.

[32]  M. Britschgi,et al.  Cross-reactivity patterns of T cells specific for iodinated contrast media. , 2007, The Journal of allergy and clinical immunology.

[33]  Pierre Vabres,et al.  Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. , 2007, The Journal of allergy and clinical immunology.

[34]  A. Romano,et al.  Brief Communication: Tolerability of Meropenem in Patients with IgE-Mediated Hypersensitivity to Penicillins , 2007, Annals of Internal Medicine.

[35]  W. Pichler.  Adverse side‐effects to biological agents , 2006, Allergy.

[36]  C. Bridts,et al.  Flow‐assisted diagnostic management of anaphylaxis from rocuronium bromide , 2006, Allergy.

[37]  J. Skyttä,et al.  Two cases of anaphylaxis to macrogol 6000 after ingestion of drug tablets , 2006, Allergy.

[38]  M. Castells.  Rapid desensitization for hypersensitivity reactions to chemotherapy agents , 2006, Current opinion in allergy and clinical immunology.

[39]  E. Pérez-Inestrosa,et al.  Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. , 2006, The Journal of allergy and clinical immunology.

[40]  A. Fishman,et al.  Successful carboplatin desensitization in patients with proven carboplatin allergy , 2005, Cancer.

[41]  P. Bousquet,et al.  Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. , 2005, The Journal of allergy and clinical immunology.

[42]  K. Lammintausta,et al.  The usefulness of skin tests to prove drug hypersensitivity , 2005, The British journal of dermatology.

[43]  P. Dewachter,et al.  Anaphylaxis to macrogol 4000 after a parenteral corticoid injection , 2005, Allergy.

[44]  R. Shekar,et al.  Is it safe to use carbapenems in patients with a history of allergy to penicillin? , 2004, The Journal of antimicrobial chemotherapy.

[45]  Michalski,et al.  Fallberichte , 2004 .

[46]  U. Matulonis,et al.  Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. , 2004, Gynecologic oncology.

[47]  W. Pichler,et al.  The lymphocyte transformation test in the diagnosis of drug hypersensitivity , 2004, Allergy.

[48]  M. Markman,et al.  Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  M. Corominas,et al.  Carboxymethylcellulose allergy as a cause of suspected corticosteroid anaphylaxis. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[50]  A. Bircher,et al.  Anaphylaxis to the Carbohydrate Carboxymethylcellulose in Parenteral Corticosteroid Preparations , 2003, Dermatology.

[51]  T. Heier,et al.  Rocuronium and cisatracurium‐positive skin tests in non‐allergic volunteers: determination of drug concentration thresholds using a dilution titration technique * , 2003, Acta anaesthesiologica Scandinavica.

[52]  R. Pettinato,et al.  Diagnosing Nonimmediate Reactions to Penicillins by in vivo Tests , 2002, International Archives of Allergy and Immunology.

[53]  M. Blanca,et al.  Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[54]  A. Romano,et al.  Clinical evaluation of Pharmacia CAP System™ RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy , 2001, Allergy.

[55]  L. Rybicki,et al.  Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  S. Halevy,et al.  Acute generalized exanthematous pustulosis associated with polysensitivity to paracetamol and bromhexine: the diagnostic role of in vitro interferon‐γ release test , 2000 .

[57]  E. Ozkaya-Bayazit,et al.  Drug related clinical pattern in fixed drug eruption. , 2000, European journal of dermatology : EJD.

[58]  Halil Bayazit,et al.  Topical provocation in 27 cases of cotrimoxazole‐inducedxed drug eruption , 1999, Contact dermatitis.

[59]  J. Roujeau,et al.  Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis , 1996, Contact dermatitis.

[60]  H. Chan,et al.  Cross-reactivity in fixed drug eruptions to tetracyclines. , 1996, Archives of dermatology.

[61]  J. Sastre,et al.  Clinical cross‐reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin , 1996, Allergy.

[62]  D. Moneret-vautrin,et al.  Cross-reactivity of rocuronium with other neuromuscular blocking agents. , 1995, European journal of anaesthesiology. Supplement.

[63]  W. F. Dunn,et al.  Anaphylaxis induced by the carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog). , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[64]  M. Audícana,et al.  Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross‐reactivity with cephalosporin , 1994, Allergy.

[65]  K. Alanko,et al.  Topical provocation of fixed drug eruption , 1987, The British journal of dermatology.

[66]  H. Tagami,et al.  Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. , 1983, Archives of dermatology.

[67]  M. Fernández‐Nieto,et al.  Basophil activation test in a case of systemic hypersensitivity reaction to infliximab with good tolerance to another anti-TNF-alpha agent (adalimumab). , 2010, Journal of investigational allergology & clinical immunology.

[68]  C. González‐Herrada,et al.  Successful adalimumab desensitization after generalized urticaria and rhinitis. , 2009, Journal of investigational allergology & clinical immunology.

[69]  T. Lobera,et al.  Immediate hypersensitivity to corticosteroids. , 2006, Journal of investigational allergology & clinical immunology.

[70]  P. Gamboa,et al.  Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. , 2004, Journal of investigational allergology & clinical immunology.

[71]  R. Mirakhur,et al.  Use of intermediate acting muscle relaxants by infusion: the future. , 1997, Acta anaesthesiologica Belgica.

[72]  A. Romano,et al.  Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to beta-lactam antibiotics. , 1993, Journal of investigational allergology & clinical immunology.

[73]  J. Dry,et al.  Systemic allergic reactions to corticosteroids. , 1991, The Journal of asthma : official journal of the Association for the Care of Asthma.